These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 21295285)
1. Torsade de pointes induced by citalopram and amiodarone. Fayssoil A; Issi J; Guerbaa M; Raynaud JC; Heroguelle V Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):165-8. PubMed ID: 21295285 [TBL] [Abstract][Full Text] [Related]
2. Citalopram induced torsade de pointes, a rare life threatening side effect. Kanjanauthai S; Kanluen T; Chareonthaitawee P Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753 [TBL] [Abstract][Full Text] [Related]
3. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome. Wegener FT; Ehrlich JR; Hohnloser SH Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559 [No Abstract] [Full Text] [Related]
4. Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone. Atar S; Freedberg NA; Antonelli D; Rosenfeld T Pacing Clin Electrophysiol; 2003 Mar; 26(3):785-6. PubMed ID: 12698686 [TBL] [Abstract][Full Text] [Related]
5. Torsade de pointes during combined treatment with risperidone and citalopram. Blaschke D; Parwani AS; Huemer M; Rolf S; Boldt LH; Dietz R; Haverkamp W Pharmacopsychiatry; 2007 Nov; 40(6):294-5. PubMed ID: 18030657 [No Abstract] [Full Text] [Related]
6. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature. Wei A; Peng J; Gu Z; Li J Medicine (Baltimore); 2017 Dec; 96(49):e9071. PubMed ID: 29245320 [TBL] [Abstract][Full Text] [Related]
7. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949 [TBL] [Abstract][Full Text] [Related]
8. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease. Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055 [TBL] [Abstract][Full Text] [Related]
9. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686 [TBL] [Abstract][Full Text] [Related]
11. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade. Skanes AC; Morton BC; Green MS; Tang AS Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970 [TBL] [Abstract][Full Text] [Related]
12. Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia-induced-cardiomyopathy. Yonai R; Kawabata M; Maeda S; Kawashima T; Tsuda Y; Nakasone T; Nakane H; Hirao K Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12810. PubMed ID: 33070441 [TBL] [Abstract][Full Text] [Related]
13. Citalopram, escitalopram: no more effective than other SSRIs, but more toxic. Prescrire Int; 2016 Apr; 25(170):98. PubMed ID: 27186623 [No Abstract] [Full Text] [Related]
14. Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy. Takahashi K; Yamashita M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S; Takemoto M; Utsunomiya Y; Hyodo T Ann Noninvasive Electrocardiol; 2021 Nov; 26(6):e12842. PubMed ID: 33755267 [TBL] [Abstract][Full Text] [Related]
15. TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY. Lakušić N; Slivnjak V; Ciglenečki N; Cerovec D Acta Clin Croat; 2019 Dec; 58(4):751-756. PubMed ID: 32665746 [TBL] [Abstract][Full Text] [Related]
16. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval. Di Micoli A; Zambruni A; Bracci E; Benazzi B; Zappoli P; Berzigotti A; Zoli M; Bernardi M; Trevisani F Dig Liver Dis; 2009 Jul; 41(7):535-8. PubMed ID: 18294935 [TBL] [Abstract][Full Text] [Related]
17. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685 [TBL] [Abstract][Full Text] [Related]
18. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401 [TBL] [Abstract][Full Text] [Related]
19. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy. Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388 [TBL] [Abstract][Full Text] [Related]